We are happy to announce a research collaboration with 3Helix Inc. (USA), the developer of the Collagen Hybridizing Peptide (CHP) technology which targets damaged or denatured collagen in biological samples with high specificity. This interesting collaboration is investigating skin damage using our Phenion® Full-Thickness Skin Models and 3Helix’s CHPs. By joining forces, we are looking forward to developing an innovative skin testing kit that can provide a standardized way to evaluate skin damage in vitro.
Aug 18, 2020 Düsseldorf / Germany
Cooperation in the field of collagen research
Phenion FT Skin Model stained with H&E (left side) and the R-CHP reagent (after heating). The red staining visualizes the newly synthesized collagen in the dermal compartment of the skin model.
